Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Botto · SciRah

Researcher profile · Semantic Scholar

B. Botto

Share profile

B. Botto — researcher profile on SciRah

h-index: 27
Works: 151
Citations: 2,937

Most-cited papers

90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.
F. Morschhauser, J. Radford, A. van Hoof, B. Botto +8 more
2013Journal of Clinical Oncology189 citations
Semantic Scholar
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.
L. Ceriani, M. Martelli, P. Zinzani, A. Ferreri +16 more
2015Blood177 citations Open access
Semantic Scholar
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
U. Vitolo, A. Chiappella, S. Franceschetti, A. Carella +20 more
2014The Lancet Oncology177 citations
Semantic Scholar
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.
F. Merli, S. Luminari, A. Tucci, A. Arcari +41 more
2021Journal of Clinical Oncology152 citations Open access
Semantic Scholar
MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial
A. Ferreri, J. Doorduijn, A. Re, M. G. Cabras +30 more
2021The Lancet Haematology98 citations Open access
Semantic Scholar
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination.
G. Benevolo, A. Stacchini, M. Spina, A. Ferreri +16 more
2012Blood86 citations Open access
Semantic Scholar
Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials
P. Zinzani, S. Viviani, A. Anastasia, U. Vitolo +11 more
2013Haematologica84 citations Open access
Semantic Scholar
Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi.
U. Vitolo, M. Ladetto, C. Boccomini, L. Baldini +17 more
2013Journal of Clinical Oncology65 citations Open access
Semantic Scholar
Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy
A. Filippi, A. Botticella, M. Bellò, B. Botto +8 more
2013Leukemia and Lymphoma40 citations
Semantic Scholar
Safety and efficacy of 90Yttrium‐Ibritumomab‐Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study
A. Ibatici, G. Pica, S. Nati, U. Vitolo +11 more
2014British Journal of Haematology39 citations Open access
Semantic Scholar
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy.
G. Simontacchi, A. Filippi, P. Ciammella, M. Buglione +9 more
2015International Journal of Radiation Oncology, Biology, Physics30 citations
Semantic Scholar
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
A. Conconi, A. Chiappella, A. Ferreri, A. Stathis +25 more
2024Blood Advances28 citations Open access
Semantic Scholar
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial
U. Ricardi, M. Levis, A. Evangelista, D. Gioia +25 more
2021Blood Advances28 citations Open access
Semantic Scholar
Prognostic models for primary mediastinal (thymic) B‐cell lymphoma derived from 18‐FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study
L. Ceriani, M. Martelli, A. Conconi, P. Zinzani +9 more
2017British Journal of Haematology28 citations
Semantic Scholar
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL)
C. Rusconi, A. Anastasia, A. Chiarenza, L. Marcheselli +10 more
2019British Journal of Haematology27 citations Open access
Semantic Scholar
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas
F. Stella, A. Chiappella, B. Casadei, S. Bramanti +26 more
2024Blood Cancer Discovery25 citations Open access
Semantic Scholar
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi
F. Zaja, S. Ferrero, C. Stelitano, A. Ferrari +18 more
2017Haematologica25 citations Open access
Semantic Scholar
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin’s lymphoma
C. Pellegrini, A. Broccoli, A. Pulsoni, L. Rigacci +38 more
2017OncoTarget23 citations Open access
Semantic Scholar
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced‐stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi
L. Marcheselli, A. Bari, A. Anastasia, B. Botto +8 more
2015British Journal of Haematology23 citations Open access
Semantic Scholar
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G‐CSF mobilization
G. Rossi, C. Skert, E. Morello, C. Almici +14 more
2015Hematological Oncology23 citations
Semantic Scholar
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
A. Tucci, F. Merli, A. Fabbri, L. Marcheselli +26 more
2022Haematologica21 citations Open access
Semantic Scholar
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL
M. Tisi, R. Moia, C. Patti, A. Evangelista +24 more
2023Blood Advances20 citations Open access
Semantic Scholar
INTENSIFIED (INTRAVENOUS AND INTRATHECAL) CNS PROPHYLAXIS IN PRIMARY TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: 5‐YEAR RESULTS OF THE IELSG30 TRIAL
A. Conconi, A. Chiappella, L. Orsucci, G. Gaidano +12 more
2021Hematological Oncology19 citations
Semantic Scholar
ABVD vs BEACOPP escalated in advanced‐stage Hodgkin’s lymphoma: Results from a multicenter European study
P. Mondello, C. Musolino, I. Dogliotti, J. Bohn +14 more
2020American journal of hematology/oncology19 citations Open access
Semantic Scholar
Potential Benefit of Involved‐Field Radiotherapy for Patients With Relapsed‐Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation
M. Levis, C. Piva, A. Filippi, B. Botto +8 more
2017Clinical Lymphoma, Myeloma & Leukemia19 citations
Semantic Scholar
Follicular Lymphoma: The Management of Elderly Patient
A. Castellino, Elisa Santambrogio, M. Nicolosi, B. Botto +2 more
2016Mediterranean Journal of Hematology and Infectious Diseases16 citations Open access
Semantic Scholar
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
A. Arcari, L. Rigacci, A. Tucci, Benedetta Puccini +33 more
2023Blood Advances14 citations Open access
Semantic Scholar
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma
A. Broccoli, C. Pellegrini, A. Di Rocco, Benedetta Puccini +38 more
2017Haematologica14 citations Open access
Semantic Scholar
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience
Fulvio Massaro, V. Pavone, P. Stefani, B. Botto +25 more
2021Hematological Oncology13 citations Open access
Semantic Scholar
IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL
M. Martelli, E. Zucca, B. Botto, I. Kryachok +32 more
2021Hematological Oncology13 citations Open access
Semantic Scholar
The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments
A. Bari, R. Marcheselli, S. Sacchi, A. Re +17 more
2019Annals of Hematology13 citations Open access
Semantic Scholar
Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
P. Ciammella, A. Filippi, G. Simontacchi, M. Buglione +8 more
2016British Journal of Radiology13 citations Open access
Semantic Scholar
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
M. Gotti, R. Sciarra, A. Pulsoni, F. Merli +37 more
2023HemaSphere12 citations Open access
Semantic Scholar
The elderly prognostic index predicts early mortality in older patients with diffuse large B‐cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
E. Cencini, A. Tucci, Benedetta Puccini, F. Cavallo +26 more
2022Hematological Oncology10 citations
Semantic Scholar
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?
M. Novo, G. Nowakowski, T. Habermann, T. Witzig +8 more
2020Leukemia and Lymphoma9 citations
Semantic Scholar
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
M. Moretti, A. M. Liberati, L. Rigacci, Benedetta Puccini +10 more
2021Clinical Lymphoma, Myeloma & Leukemia8 citations Open access
Semantic Scholar
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.
E. Zucca, A. Davies, I. Kryachok, G. Ciccone +16 more
2023Journal of Clinical Oncology7 citations
Semantic Scholar
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia
I. Dogliotti, S. Ragaini, F. Vassallo, Elia Boccellato +12 more
2021Journal of Personalized Medicine7 citations Open access
Semantic Scholar
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study
L. Rigacci, Benedetta Puccini, A. Broccoli, M. Dona +16 more
2019Annals of Hematology7 citations
Semantic Scholar
OC-0502 Role of consolidation RT to bulky lesions of advanced Hodgkin lymphoma: results of FIL HD0801 trial
U. Ricardi, M. Levis, A. Evangelista, D. Gioia +20 more
2019Radiotherapy and Oncology7 citations Open access
Semantic Scholar
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
C. Ciochetto, B. Botto, R. Passera, M. Bellò +11 more
2018Annals of Hematology7 citations
Semantic Scholar
B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)
M. Balzarotti, E. Brusamolino, E. Angelucci, A. Carella +21 more
2016Leukemia and Lymphoma7 citations
Semantic Scholar
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.
E. Zucca, L. Ceriani, G. Ciccone, A. Di Rocco +36 more
2025Blood6 citations
Semantic Scholar
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis
A. Dodero, G. Ceparano, B. Casadei, P. Angelillo +20 more
2025Blood Advances6 citations Open access
Semantic Scholar
Real-World Data of Nivolumab in Classical Hodgkin Lymphoma: Results from the Italian Expanded Access Programme
A. Santoro, F. D'Alo', P. Zinzani, L. Rigacci +16 more
20176 citations
Semantic Scholar
Final Results Of Phase II Study Of Lenalidomide Plus Rituximab-CHOP21 In Elderly Untreated Diffuse Large B-Cell Lymphoma Focusing On The Analysis Of Cell Of Origin: REAL07 Trial Of The Fondazione Italiana Linfomi
A. Chiappella, S. Franceschetti, A. Castellino, A. Carella +21 more
20136 citations
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
A. Pinto, G. Corazzelli, A. Evangelista, C. Patti +37 more
2023Hematological Oncology5 citations Open access
Semantic Scholar
Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem
A. Chiappella, A. Guidetti, A. Dodero, S. Bramanti +18 more
2021Blood5 citations Open access
Semantic Scholar
A Prospective, Observational Study Evaluating Early Subclinical Cardiotoxicity with Global Longitudinal Strain Imaging in Lymphoma Patients Treated with Chemotherapy +/- Mediastinal Radiation Therapy: The CARDIOCARE Project
M. Levis, V. De Luca, S. Bartoncini, B. Botto +15 more
2018International Journal of Radiation Oncology, Biology, Physics5 citations
Semantic Scholar
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
M. Clerico, I. Dogliotti, P. Ghione, V. Zilioli +12 more
2022Journal of Personalized Medicine4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Merli×17
Invite
F. Merli — researcher profile on SciRah
U. Vitolo×17
Invite
U. Vitolo — researcher profile on SciRah
P. Zinzani×16
Invite
P. Zinzani — researcher profile on SciRah
M. Spina×14
Invite
M. Spina — researcher profile on SciRah

×11

Invite

V. Pavone — researcher profile on SciRah

Invite

A. Tucci — researcher profile on SciRah

Invite

A. Re — researcher profile on SciRah

Benedetta Puccini×11

Invite

Benedetta Puccini — researcher profile on SciRah

Invite

V. Zilioli — researcher profile on SciRah

Invite

M. Tani — researcher profile on SciRah

Invite

L. Rigacci — researcher profile on SciRah

A. Chiappella×10

Invite

A. Chiappella — researcher profile on SciRah